• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过网络分析重新利用药物:精神疾病的机遇

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.

作者信息

Truong Trang T T, Panizzutti Bruna, Kim Jee Hyun, Walder Ken

机构信息

IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong 3220, Australia.

Mental Health Theme, The Florey Institute of Neuroscience and Mental Health, Parkville 3010, Australia.

出版信息

Pharmaceutics. 2022 Jul 14;14(7):1464. doi: 10.3390/pharmaceutics14071464.

DOI:10.3390/pharmaceutics14071464
PMID:35890359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9319329/
Abstract

Despite advances in pharmacology and neuroscience, the path to new medications for psychiatric disorders largely remains stagnated. Drug repurposing offers a more efficient pathway compared with de novo drug discovery with lower cost and less risk. Various computational approaches have been applied to mine the vast amount of biomedical data generated over recent decades. Among these methods, network-based drug repurposing stands out as a potent tool for the comprehension of multiple domains of knowledge considering the interactions or associations of various factors. Aligned well with the poly-pharmacology paradigm shift in drug discovery, network-based approaches offer great opportunities to discover repurposing candidates for complex psychiatric disorders. In this review, we present the potential of network-based drug repurposing in psychiatry focusing on the incentives for using network-centric repurposing, major network-based repurposing strategies and data resources, applications in psychiatry and challenges of network-based drug repurposing. This review aims to provide readers with an update on network-based drug repurposing in psychiatry. We expect the repurposing approach to become a pivotal tool in the coming years to battle debilitating psychiatric disorders.

摘要

尽管药理学和神经科学取得了进展,但用于治疗精神疾病的新药研发之路在很大程度上仍然停滞不前。与从头研发新药相比,药物重新利用提供了一条成本更低、风险更小的更高效途径。各种计算方法已被应用于挖掘近几十年来产生的大量生物医学数据。在这些方法中,基于网络的药物重新利用作为一种强大的工具脱颖而出,它能够考虑各种因素的相互作用或关联,从而理解多个知识领域。基于网络的方法与药物研发中多药理学范式的转变高度契合,为发现用于治疗复杂精神疾病的重新利用候选药物提供了巨大机遇。在本综述中,我们阐述了基于网络的药物重新利用在精神病学中的潜力,重点关注以网络为中心进行重新利用的动机、主要的基于网络的重新利用策略和数据资源、在精神病学中的应用以及基于网络的药物重新利用所面临的挑战。本综述旨在为读者提供有关基于网络的药物重新利用在精神病学领域的最新情况。我们期望这种重新利用方法在未来几年成为对抗使人衰弱的精神疾病的关键工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/cbecc46c7a98/pharmaceutics-14-01464-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/4cb21ba55307/pharmaceutics-14-01464-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/9aa43f8d877c/pharmaceutics-14-01464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/db273f1c858f/pharmaceutics-14-01464-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/a9ab4a776dd2/pharmaceutics-14-01464-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/cbecc46c7a98/pharmaceutics-14-01464-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/4cb21ba55307/pharmaceutics-14-01464-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/9aa43f8d877c/pharmaceutics-14-01464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/db273f1c858f/pharmaceutics-14-01464-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/a9ab4a776dd2/pharmaceutics-14-01464-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/9319329/cbecc46c7a98/pharmaceutics-14-01464-g005.jpg

相似文献

1
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.通过网络分析重新利用药物:精神疾病的机遇
Pharmaceutics. 2022 Jul 14;14(7):1464. doi: 10.3390/pharmaceutics14071464.
2
Computationally repurposing drugs for breast cancer subtypes using a network-based approach.基于网络的方法对乳腺癌亚型进行药物的重新定位。
BMC Bioinformatics. 2022 Apr 20;23(1):143. doi: 10.1186/s12859-022-04662-6.
3
Signature-based approaches for informed drug repurposing: targeting CNS disorders.基于特征的知情药物再利用方法:针对中枢神经系统疾病
Neuropsychopharmacology. 2021 Jan;46(1):116-130. doi: 10.1038/s41386-020-0752-6. Epub 2020 Jun 30.
4
Application of artificial intelligence and machine learning in drug repurposing.人工智能和机器学习在药物重定位中的应用。
Prog Mol Biol Transl Sci. 2024;205:171-211. doi: 10.1016/bs.pmbts.2024.03.030. Epub 2024 Mar 31.
5
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.重振癌症治疗:探索药物重新利用的作用。
Cancers (Basel). 2024 Apr 11;16(8):1463. doi: 10.3390/cancers16081463.
6
Computational Drug Repurposing: Current Trends.计算药物再利用:现状趋势。
Curr Med Chem. 2019;26(28):5389-5409. doi: 10.2174/0929867325666180530100332.
7
Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.用新手段重新构想老药:药物重用于神经疾病的机制、策略和显著成功案例。
Prog Mol Biol Transl Sci. 2024;205:23-70. doi: 10.1016/bs.pmbts.2024.03.029. Epub 2024 Apr 3.
8
Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder.利用基因调控网络分析来重新利用药物治疗双相情感障碍。
J Affect Disord. 2024 Apr 1;350:230-239. doi: 10.1016/j.jad.2024.01.034. Epub 2024 Jan 6.
9
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.人工智能和基于网络的方法在新冠病毒药物再利用中的综合综述
Biomed Pharmacother. 2022 Sep;153:113350. doi: 10.1016/j.biopha.2022.113350. Epub 2022 Jun 28.
10
Advancements in Drug Repurposing: Examples in Psychiatric Medications.药物再利用的进展:精神药物的实例。
Int J Mol Sci. 2023 Jul 1;24(13):11000. doi: 10.3390/ijms241311000.

引用本文的文献

1
Prioritizing FDA approved therapeutics for treating sepsis phenotypes: A network modeling approach based on neutrophil proteomics.确定用于治疗脓毒症表型的FDA批准的治疗方法的优先级:一种基于中性粒细胞蛋白质组学的网络建模方法。
Front Immunol. 2025 Aug 14;16:1646141. doi: 10.3389/fimmu.2025.1646141. eCollection 2025.
2
Leveraging pleiotropy for the improved treatment of psychiatric disorders.利用基因多效性改善精神疾病的治疗
Mol Psychiatry. 2025 Feb;30(2):705-721. doi: 10.1038/s41380-024-02771-7. Epub 2024 Oct 10.
3
Human protein-protein interaction networks: A topological comparison review.

本文引用的文献

1
Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder.共表达网络揭示长链非编码RNA作为治疗双相情感障碍药物的分子靶点。
Front Pharmacol. 2022 Apr 8;13:873271. doi: 10.3389/fphar.2022.873271. eCollection 2022.
2
PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool.药物组学:一个物种和组织特异性的药物特征数据库以及基于基因网络的药物重新定位工具。
iScience. 2022 Mar 10;25(4):104052. doi: 10.1016/j.isci.2022.104052. eCollection 2022 Apr 15.
3
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.
人类蛋白质-蛋白质相互作用网络:拓扑比较综述。
Heliyon. 2024 Mar 1;10(5):e27278. doi: 10.1016/j.heliyon.2024.e27278. eCollection 2024 Mar 15.
4
Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.全基因组关联研究提示脂质代谢通路功能障碍与抗精神病药引起的体重增加有关:多祖验证。
Mol Psychiatry. 2024 Jun;29(6):1857-1868. doi: 10.1038/s41380-024-02447-2. Epub 2024 Feb 9.
5
CaMKK2 as an emerging treatment target for bipolar disorder.钙调蛋白激酶激酶 2 作为双相情感障碍的新兴治疗靶点。
Mol Psychiatry. 2023 Nov;28(11):4500-4511. doi: 10.1038/s41380-023-02260-3. Epub 2023 Sep 20.
6
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine.代谢调节治疗双相抑郁:曲美他嗪的作用机制和靶点。
Mol Psychiatry. 2023 Aug;28(8):3231-3242. doi: 10.1038/s41380-023-02134-8. Epub 2023 Jun 29.
7
DEDTI versus IEDTI: efficient and predictive models of drug-target interactions.DEDTI 与 IEDTI:药物-靶标相互作用的高效预测模型。
Sci Rep. 2023 Jun 7;13(1):9238. doi: 10.1038/s41598-023-36438-0.
JASPAR 2022:转录因子结合谱开放获取数据库的第 9 个版本。
Nucleic Acids Res. 2022 Jan 7;50(D1):D165-D173. doi: 10.1093/nar/gkab1113.
4
Challenges and opportunities in network-based solutions for biological questions.网络解决方案在生物问题上的挑战与机遇。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab437.
5
Network medicine for disease module identification and drug repurposing with the NeDRex platform.基于 NeDRex 平台的疾病模块识别和药物重利用的网络医学。
Nat Commun. 2021 Nov 25;12(1):6848. doi: 10.1038/s41467-021-27138-2.
6
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.2022 年 IUPHAR/BPS 药理学指南:为 COVID-19、疟疾和抗菌药物药物治疗学。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294. doi: 10.1093/nar/gkab1010.
7
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents.治疗靶点数据库更新 2022:通过丰富的靶向药物比较数据促进药物发现。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1398-D1407. doi: 10.1093/nar/gkab953.
8
GRAND: a database of gene regulatory network models across human conditions.GRAND:一个跨人类条件的基因调控网络模型数据库。
Nucleic Acids Res. 2022 Jan 7;50(D1):D610-D621. doi: 10.1093/nar/gkab778.
9
Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children.基于网络特异性核心基因的药物重新定位识别出治疗儿童自闭症谱系障碍的潜在药物。
Comput Struct Biotechnol J. 2021 Jul 1;19:3908-3921. doi: 10.1016/j.csbj.2021.06.046. eCollection 2021.
10
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.